XBIO Earnings

Quarterly EPS
$-0.28
Q3 2024
$-0.68
Q4 2024
$-0.59
Q1 2025
$-0.45
Q2 2025
$-0.33
Q3 2025
$-0.27
Q4 2025
$-0.20
Q1 2026
$-0.41
Q2 2026
Latest Revenue660.6K
Latest Net Income-929695
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.41660.6K-929695+12.0%+8.9%
Q1 2026-$0.20806.9K-456382+36.0%+66.1%
Q4 2025-$0.270-579076+60.3%
Q3 2025-$0.330-509940-17.9%
Q2 2025-$0.45589.9K-688703-18.8%+45.8%
Q1 2025-$0.59593.3K-903141+16.1%+24.4%
Q4 2024-$0.680-1054521-100.0%+10.5%
Q3 2024-$0.280-436671+59.4%
Q2 2024-$0.83726.4K-1273970
Q1 2024-$0.78510.8K-1195113
Q4 2023-$0.762.5M-1171506
Q3 2023-$0.690-1055555
Xenetic Biosciences (XBIO) — Earnings